Esther Dalfó

3.7k total citations
42 papers, 3.1k citations indexed

About

Esther Dalfó is a scholar working on Neurology, Physiology and Molecular Biology. According to data from OpenAlex, Esther Dalfó has authored 42 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Neurology, 20 papers in Physiology and 18 papers in Molecular Biology. Recurrent topics in Esther Dalfó's work include Parkinson's Disease Mechanisms and Treatments (22 papers), Alzheimer's disease research and treatments (15 papers) and Prion Diseases and Protein Misfolding (6 papers). Esther Dalfó is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (22 papers), Alzheimer's disease research and treatments (15 papers) and Prion Diseases and Protein Misfolding (6 papers). Esther Dalfó collaborates with scholars based in Spain, United States and United Kingdom. Esther Dalfó's co-authors include Isidró Ferrer, Manuel Portero-Otı́n, Reinald Pamplona, Victòria Ayala, Marta Barrachina, Teresa Gómez‐Isla, Marı́a Josep Bellmunt, Margarita Carmona, Gerard Muntané and Elena M. Ribé and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Brain.

In The Last Decade

Esther Dalfó

42 papers receiving 3.0k citations

Peers

Esther Dalfó

PHYSI

NEURO

CMN

NEURO

Chengsong Xie United States

Irina G. Stavrovskaya United States

Latha Devi United States

Reidun Torp Norway

Susan Leight United States

Amy Manning-Bog United States

Cristina Guardia‐Laguarta United States

Hanna Ksiȩżak-Reding United States

Jessie Theuns Belgium

Masaaki Waragai Japan

Chengsong Xie United States

Esther Dalfó

1.2k ×0.9

PHYSI

1.7k ×1.4

NEURO

1.8k ×1.5

1.0k ×1.2

CMN

700 ×1.3

NEURO

Citations per year, relative to Esther Dalfó Esther Dalfó (= 1×) peers Chengsong Xie

Countries citing papers authored by Esther Dalfó

Since Specialization

Citations

This map shows the geographic impact of Esther Dalfó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Dalfó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Dalfó more than expected).

Fields of papers citing papers by Esther Dalfó

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Dalfó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Dalfó. The network helps show where Esther Dalfó may publish in the future.

Co-authorship network of co-authors of Esther Dalfó

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Dalfó. A scholar is included among the top collaborators of Esther Dalfó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Dalfó. Esther Dalfó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Assié, Adrien, Anna Esteve‐Codina, Marta Gut, et al.. (2024). Caenorhabditis elegans endorse bacterial nanocellulose fibers as functional dietary Fiber reducing lipid markers. Carbohydrate Polymers. 331. 121815–121815. 6 indexed citations

Guha, Sanjib, Stéphane Fourcade, Janani Parameswaran, et al.. (2020). The peroxisomal fatty acid transporter ABCD1/PMP-4 is required in the C. elegans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy. Free Radical Biology and Medicine. 152. 797–809. 19 indexed citations

Vidal, Enrique, Silvia M. Vidal, Mauricio Sáez, et al.. (2016). Whole exome sequencing of Rett syndrome-like patients reveals the mutational diversity of the clinical phenotype. Human Genetics. 135(12). 1343–1354. 48 indexed citations

Ferrer, Isidró, Irene López‐González, Margarita Carmona, et al.. (2011). Neurochemistry and the non-motor aspects of PD. Neurobiology of Disease. 46(3). 508–526. 68 indexed citations

Ferrer, Isidró, et al.. (2010). Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. Journal of Neural Transmission. 118(5). 821–839. 148 indexed citations

Pamplona, Reinald, Ekaterina V. Ilieva, Victòria Ayala, et al.. (2008). Maillard Reaction versus Other Nonenzymatic Modifications in Neurodegenerative Processes. Annals of the New York Academy of Sciences. 1126(1). 315–319. 17 indexed citations

Ferrer, Isidró, et al.. (2007). Abnormal levels of prohibitin and ATP synthase in the substantia nigra and frontal cortex in Parkinson's disease. Neuroscience Letters. 415(3). 205–209. 69 indexed citations

Muntané, Gerard, Esther Dalfó, M. Rey, et al.. (2006). Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease. Journal of Neurochemistry. 99(1). 177–185. 48 indexed citations

Dalfó, Esther & Isidró Ferrer. (2006). Early α-synuclein lipoxidation in neocortex in Lewy body diseases. Neurobiology of Aging. 29(3). 408–417. 69 indexed citations

10.

Pamplona, Reinald, Esther Dalfó, Victòria Ayala, et al.. (2005). Proteins in Human Brain Cortex Are Modified by Oxidation, Glycoxidation, and Lipoxidation. Journal of Biological Chemistry. 280(22). 21522–21530. 234 indexed citations

11.

Nieto, M. Ángela, Francisco J. Gil‐Bea, Esther Dalfó, et al.. (2005). Increased sensitivity to MPTP in human α-synuclein A30P transgenic mice. Neurobiology of Aging. 27(6). 848–856. 80 indexed citations

12.

Dalfó, Esther & Isidró Ferrer. (2005). α-Synuclein binding to rab3a in multiple system atrophy. Neuroscience Letters. 380(1-2). 170–175. 37 indexed citations

13.

Barrachina, Marta, Esther Castaño, Esther Dalfó, et al.. (2005). Reduced ubiquitin C-terminal hydrolase-1 expression levels in dementia with Lewy bodies. Neurobiology of Disease. 22(2). 265–273. 59 indexed citations

14.

Rodríguez, Alicia, et al.. (2005). Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt–Jakob disease. Neurobiology of Aging. 27(12). 1807–1815. 71 indexed citations

15.

Rodríguez, Alicia, et al.. (2005). Metabotropic glutamate receptor/phospholipase C pathway: A vulnerable target to Creutzfeldt-Jakob disease in the cerebral cortex. Neuroscience. 131(4). 825–832. 14 indexed citations

16.

Dalfó, Esther, et al.. (2005). Evidence of Oxidative Stress in the Neocortex in Incidental Lewy Body Disease. Journal of Neuropathology & Experimental Neurology. 64(9). 816–830. 211 indexed citations

17.

Albasanz, José Luís, Esther Dalfó, Isidró Ferrer, & Mairena Martı́n. (2005). Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes. Neurobiology of Disease. 20(3). 685–693. 91 indexed citations

18.

Dalfó, Esther, Marta Barrachina, José Luís Rosa, Santiago Ambrosio, & Isidró Ferrer. (2004). Abnormal α-synuclein interactions with rab3a and rabphilin in diffuse Lewy body disease. Neurobiology of Disease. 16(1). 92–97. 79 indexed citations

19.

Gómez-Santos, Cristina, Marta Barrachina, Pol Giménez‐Xavier, et al.. (2004). Induction of C/EBPβ and GADD153 expression by dopamine in human neuroblastoma cells. Brain Research Bulletin. 65(1). 87–95. 47 indexed citations

20.

Dalfó, Esther, M. Hernández, José M. Lizcano, Keith F. Tipton, & Mercedes Unzeta. (2003). Activation of human lung semicarbazide sensitive amine oxidase by a low molecular weight component present in human plasma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1638(3). 278–286. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact